• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Regulation of p53 tetramerization and nuclear export by ARC.ARC对p53四聚化及核输出的调控
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20826-31. doi: 10.1073/pnas.0710017104. Epub 2007 Dec 17.
2
Induction of the apoptosis inhibitor ARC by Ras in human cancers.Ras 诱导人类癌症中凋亡抑制剂 ARC 的表达。
J Biol Chem. 2010 Jun 18;285(25):19235-45. doi: 10.1074/jbc.M110.114892. Epub 2010 Apr 14.
3
HPV-mediated nuclear export of HP1γ drives cervical tumorigenesis by downregulation of p53.HPV 介导的 HP1γ 核输出通过下调 p53 驱动宫颈癌发生。
Cell Death Differ. 2020 Sep;27(9):2537-2551. doi: 10.1038/s41418-020-0520-5. Epub 2020 Mar 23.
4
The nuclear exporter, Crm1, is regulated by NFY and Sp1 in cancer cells and repressed by p53 in response to DNA damage.核输出蛋白Crm1在癌细胞中受NFY和Sp1调控,并在DNA损伤时被p53抑制。
Biochim Biophys Acta. 2011 Jul;1809(7):316-26. doi: 10.1016/j.bbagrm.2011.05.017. Epub 2011 Jun 13.
5
Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain.一种新的与癌症相关的p53突变体的特征分析,该突变体在四聚化结构域存在错义突变(K351N)。
Cell Cycle. 2009 Oct 15;8(20):3396-405. doi: 10.4161/cc.8.20.9910. Epub 2009 Oct 24.
6
Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis.Importin 7 和 exportin 1 将 c-Myc 和 p53 联系起来,共同调节核糖体的生物发生。
Mol Cell. 2012 Jan 27;45(2):222-32. doi: 10.1016/j.molcel.2011.11.022.
7
CRM1-dependent p53 nuclear accumulation in lung lesions of a bitransgenic mouse lung tumor model.CRM1 依赖性 p53 核积累在双转基因小鼠肺肿瘤模型肺病变中。
Oncol Rep. 2011 Jul;26(1):223-8. doi: 10.3892/or.2011.1279. Epub 2011 Apr 21.
8
Retinoic acid-induced apoptosis of the CHP134 neuroblastoma cell line is associated with nuclear accumulation of p53 and is rescued by the GDNF/Ret signal.维甲酸诱导的CHP134神经母细胞瘤细胞系凋亡与p53的核积累有关,并被GDNF/Ret信号挽救。
Med Pediatr Oncol. 2001 Jan;36(1):122-6. doi: 10.1002/1096-911X(20010101)36:1<122::AID-MPO1029>3.0.CO;2-R.
9
Subcellular Distribution of p53 by the p53-Responsive lncRNA Determines Chemotherapeutic Response in Neuroblastoma.p53 反应性长非编码 RNA 决定神经母细胞瘤的化疗反应的亚细胞分布。
Cancer Res. 2021 Mar 15;81(6):1457-1471. doi: 10.1158/0008-5472.CAN-19-3499. Epub 2020 Dec 28.
10
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.XPO1 依赖的核输出是 KRAS 突变型肺癌中的一个可药物靶向的弱点。
Nature. 2016 Oct 6;538(7623):114-117. doi: 10.1038/nature19771. Epub 2016 Sep 28.

引用本文的文献

1
Correlation of p53 oligomeric status and its subcellular localization in the presence of the AML-associated NPM mutant.在急性髓系白血病相关的核仁磷酸蛋白(NPM)突变存在的情况下,p53寡聚状态与其亚细胞定位的相关性。
PLoS One. 2025 May 7;20(5):e0322096. doi: 10.1371/journal.pone.0322096. eCollection 2025.
2
Role of apoptosis repressor with caspase recruitment domain in human health and chronic diseases.凋亡抑制因子含半胱氨酸的天冬氨酸蛋白水解酶募集结构域在人类健康和慢性疾病中的作用。
Ann Med. 2024 Dec;56(1):2409958. doi: 10.1080/07853890.2024.2409958. Epub 2024 Oct 1.
3
How Do Cancer-Related Mutations Affect the Oligomerisation State of the p53 Tetramerisation Domain?癌症相关突变如何影响p53四聚化结构域的寡聚化状态?
Curr Issues Mol Biol. 2023 Jun 7;45(6):4985-5004. doi: 10.3390/cimb45060317.
4
A double-edged sword: role of apoptosis repressor with caspase recruitment domain (ARC) in tumorigenesis and ischaemia/reperfusion (I/R) injury.双刃剑:含半胱氨酸天冬氨酸蛋白酶募集结构域的凋亡抑制因子(ARC)在肿瘤发生和缺血/再灌注(I/R)损伤中的作用。
Apoptosis. 2023 Apr;28(3-4):313-325. doi: 10.1007/s10495-022-01802-4. Epub 2023 Jan 18.
5
Dysregulation of cellular membrane homeostasis as a crucial modulator of cancer risk.细胞膜内稳态失调作为癌症风险的关键调节剂。
FEBS J. 2024 Apr;291(7):1299-1352. doi: 10.1111/febs.16665. Epub 2022 Nov 7.
6
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.循环肿瘤细胞转录组学作为转移性乳腺癌的活检替代物。
Ann Surg Oncol. 2022 May;29(5):2882-2894. doi: 10.1245/s10434-021-11135-2. Epub 2022 Jan 9.
7
Pathogen Moonlighting Proteins: From Ancestral Key Metabolic Enzymes to Virulence Factors.病原体兼职蛋白:从古老的关键代谢酶到毒力因子
Microorganisms. 2021 Jun 15;9(6):1300. doi: 10.3390/microorganisms9061300.
8
Conversion of the death inhibitor ARC to a killer activates pancreatic β cell death in diabetes.将死亡抑制剂 ARC 转化为杀手可激活糖尿病中的胰腺 β 细胞死亡。
Dev Cell. 2021 Mar 22;56(6):747-760.e6. doi: 10.1016/j.devcel.2021.02.011. Epub 2021 Mar 4.
9
Role of apoptosis repressor with caspase recruitment domain (ARC) in cell death and cardiovascular disease.凋亡抑制因子含有半胱氨酸天冬氨酸蛋白酶募集结构域(ARC)在细胞死亡和心血管疾病中的作用。
Apoptosis. 2021 Feb;26(1-2):24-37. doi: 10.1007/s10495-020-01653-x. Epub 2021 Feb 19.
10
Expression of apoptosis repressor with caspase recruitment domain (ARC) in familial adenomatous polyposis (FAP) adenomas and its correlation with DNA mismatch repair proteins, p53, Bcl-2, COX-2 and beta-catenin.凋亡抑制因子 with caspase recruitment domain(ARC)在家族性腺瘤性息肉病(FAP)腺瘤中的表达及其与错配修复蛋白、p53、Bcl-2、COX-2 和β-连环蛋白的相关性。
Cell Commun Signal. 2021 Feb 12;19(1):15. doi: 10.1186/s12964-020-00702-x.

本文引用的文献

1
p53 in health and disease.健康与疾病中的p53
Nat Rev Mol Cell Biol. 2007 Apr;8(4):275-83. doi: 10.1038/nrm2147.
2
The apoptosis inhibitor ARC undergoes ubiquitin-proteasomal-mediated degradation in response to death stimuli: identification of a degradation-resistant mutant.凋亡抑制因子ARC在死亡刺激下会经历泛素-蛋白酶体介导的降解:一种抗降解突变体的鉴定。
J Biol Chem. 2007 Feb 23;282(8):5522-8. doi: 10.1074/jbc.M609186200. Epub 2006 Dec 1.
3
Regulation of p53 localization and activity by Ubc13.Ubc13对p53定位和活性的调控
Mol Cell Biol. 2006 Dec;26(23):8901-13. doi: 10.1128/MCB.01156-06. Epub 2006 Sep 25.
4
Exploiting the p53 pathway for the diagnosis and therapy of human cancer.利用p53信号通路进行人类癌症的诊断与治疗。
Cold Spring Harb Symp Quant Biol. 2005;70:489-97. doi: 10.1101/sqb.2005.70.049.
5
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.Bcl-2是乳腺癌的一个预后标志物,独立于诺丁汉预后指数。
Clin Cancer Res. 2006 Apr 15;12(8):2468-75. doi: 10.1158/1078-0432.CCR-05-2719.
6
Irradiation-induced translocation of p53 to mitochondria in the absence of apoptosis.在无细胞凋亡情况下,辐射诱导p53转位至线粒体。
J Biol Chem. 2005 Nov 4;280(44):37169-77. doi: 10.1074/jbc.M502052200. Epub 2005 Sep 7.
7
ARC, an apoptosis suppressor limited to terminally differentiated cells, is induced in human breast cancer and confers chemo- and radiation-resistance.ARC是一种仅限于终末分化细胞的凋亡抑制因子,在人类乳腺癌中被诱导产生,并赋予化学和放射抗性。
Cell Death Differ. 2005 Jun;12(6):682-6. doi: 10.1038/sj.cdd.4401631.
8
Apoptosis repressor with caspase recruitment domain (ARC) is expressed in cancer cells and localizes to nuclei.含半胱天冬酶募集结构域的凋亡抑制因子(ARC)在癌细胞中表达并定位于细胞核。
FEBS Lett. 2005 Apr 25;579(11):2411-5. doi: 10.1016/j.febslet.2005.03.040.
9
The p53 pathway: positive and negative feedback loops.p53信号通路:正反馈和负反馈回路
Oncogene. 2005 Apr 18;24(17):2899-908. doi: 10.1038/sj.onc.1208615.
10
ASPP1 and ASPP2 are new transcriptional targets of E2F.ASPP1和ASPP2是E2F新的转录靶点。
Cell Death Differ. 2005 Apr;12(4):369-76. doi: 10.1038/sj.cdd.4401562.

ARC对p53四聚化及核输出的调控

Regulation of p53 tetramerization and nuclear export by ARC.

作者信息

Foo Roger S-Y, Nam Young-Jae, Ostreicher Marc Jason, Metzl Mark D, Whelan Russell S, Peng Chang-Fu, Ashton Anthony W, Fu Weimin, Mani Kartik, Chin Suet-Feung, Provenzano Elena, Ellis Ian, Figg Nichola, Pinder Sarah, Bennett Martin R, Caldas Carlos, Kitsis Richard N

机构信息

Departments of Medicine and Cell Biology, Cardiovascular Research Center, and Cancer Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

出版信息

Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20826-31. doi: 10.1073/pnas.0710017104. Epub 2007 Dec 17.

DOI:10.1073/pnas.0710017104
PMID:18087040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2409226/
Abstract

Inactivation of the transcription factor p53 is central to carcinogenesis. Yet only approximately one-half of cancers have p53 loss-of-function mutations. Here, we demonstrate a mechanism for p53 inactivation by apoptosis repressor with caspase recruitment domain (ARC), a protein induced in multiple cancer cells. The direct binding in the nucleus of ARC to the p53 tetramerization domain inhibits p53 tetramerization. This exposes a nuclear export signal in p53, triggering Crm1-dependent relocation of p53 to the cytoplasm. Knockdown of endogenous ARC in breast cancer cells results in spontaneous tetramerization of endogenous p53, accumulation of p53 in the nucleus, and activation of endogenous p53 target genes. In primary human breast cancers with nuclear ARC, p53 is almost always WT. Conversely, nearly all breast cancers with mutant p53 lack nuclear ARC. We conclude that nuclear ARC is induced in cancer cells and negatively regulates p53.

摘要

转录因子p53的失活是致癌作用的核心。然而,只有大约一半的癌症具有p53功能丧失突变。在此,我们证明了一种由含半胱天冬酶募集结构域的凋亡抑制因子(ARC)使p53失活的机制,ARC是一种在多种癌细胞中诱导产生的蛋白质。ARC在细胞核中与p53四聚化结构域直接结合,抑制p53四聚化。这暴露了p53中的一个核输出信号,触发p53依赖于Crm1的转运至细胞质。敲低乳腺癌细胞中的内源性ARC会导致内源性p53自发四聚化、p53在细胞核中积累以及内源性p53靶基因的激活。在具有细胞核ARC的原发性人类乳腺癌中,p53几乎总是野生型。相反,几乎所有具有突变型p53的乳腺癌都缺乏细胞核ARC。我们得出结论,细胞核ARC在癌细胞中被诱导并对p53起负调控作用。